Gianfabio Giorgioni and Alessandro Piergentili - Free people check

(1 - 15 from 17

)

Gianfabio Giorgioni | XanEdu Customization Platform

www.academicpub.com

Author: Gianfabio Giorgioni. Results. Guest Editorial Springer Science+Business Media By: Gianfabio Giorgioni; Alessandro Piergentili; ...

ANTIDEPRESSANT-LIKE ACTIVITY OF NOVEL IMIDAZOLINE LIGANDS DIRECTED TO...

core.ac.uk

By Fabio Del Bello, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Lorenzo Di Cesare Mannelli, Laura Micheli and Carla Ghelardini

Biomolecules | Free Full-Text | Receptor Ligands as Helping Hands to...

www.mdpi.com

Fabio Del Bello , Mario Giannella, Gianfabio Giorgioni * , Alessandro Piergentili and Wilma Quaglia. Scuola di Scienze del Farmaco e dei ...

Download PDF - Springer Link

link.springer.com

Gianfabio Giorgioni, Alessandro Piergentili, Richard A. Glennon. The interplay of biological activity and chemical structure is a highly angmy intriguing problem ...

SciFeed - MDPI

www.mdpi.com

By following authors. Fabio Del Bello. Mario Giannella. Gianfabio Giorgioni. Alessandro Piergentili. Wilma Quaglia. With settings. Email: Freq: Daily, Weekly ...

All web results to the name "Gianfabio Giorgioni"

A Novel Class of Dopamine D4Receptor Ligands Altmetric

www.altmetric.com

Valerio Mammoli, Alessandro Bonifazi, Diego Dal Ben, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Maria Pigini, Wilma Quaglia, Ajiroghene ...

CCDC : Experimental Crystal Structure Determination. Fabio Del Bello, Alessandro Bonifazi, Gianfabio Giorgioni, Riccardo Petrelli, Wilma Quaglia, Angela Altomare, Aurelia Falcicchio, Rosanna Matucci, Giulio Vistoli & Alessandro Piergentili. Work published via Cambridge Crystallographic Data Centre.

Investigation of the Role of Chirality in the Interaction X-MOL

en.x-mol.com

... JoLynn B. Giancola, Emanuela Micioni Di Bonaventura, Giulio Vistoli, Gianfabio Giorgioni, Wilma Quaglia, Alessandro Piergentili, Carlo Cifani.

Novel antitumor copper(ii) complexes designed to act through...

pubs.rsc.org

c, Fabio Del Bello ORCID logo *d, Gianfabio Giorgioni ORCID logo d, Alessandro Piergentili ORCID logo d and Wilma Quaglia ORCID logo d

Role of the NMDA Receptor in the Antitumor Activity of Chiral ...

figshare.com

... Fontana Valerio Mammoli Wilma Quaglia Alessandro Bonifazi Mario Giannella Gianfabio Giorgioni Alessandro Piergentili Fabio Del Bello.

Most recent papers with the keyword Drug induced dyskinesia | Read ...

read.qxmd.com

Fabio Del Bello, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia. Levodopa (LD) is the most effective drug in the treatment of ...

Multitarget 1,4-Dioxane Compounds Combining Favorable D2‑like ...

acs.figshare.com

... H. Newman Thomas M. Keck Mario Giannella Gianfabio Giorgioni Alessandro Piergentili Loredana Cappellacci Antonio Cilia Silvia Franchini ...

The replacement of the 2-methoxy substituent of...

www.researchwithnj.com

Fabio Del Bello, Alessandro Bonifazi, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Riccardo Petrelli, Carlo Cifani, Maria Vittoria ...

Novel antitumor copper(ii) complexes designed to act through ...

pubs.rsc.org

... Carlo Santini,c Cristina Cimarelli,c Enrico Marcantoni,c Marino Petrini,c Fabio Del Bello,*dGianfabio Giorgioni,d Alessandro Piergentilid and Wilma Quagliad.

1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one...

en.x-mol.com

... Ligands with High Affinity and Selectivity for Dopamine D4 Receptor，Fabio Del Bello, Alessandro Bonifazi, Gianfabio Giorgioni, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura, Riccardo Petrelli, Alessandro Piergentili, Stefano Fontana, Valerio Mammoli, Hideaki Yano, Rosanna Matucci, Giulio Vistoli, ...